Inhibition of Grb2 expression demonstrates an important role in BCR–ABL-mediated MAPK activation and transformation of primary human hematopoietic cells-Reference-Cited by-同舟云学术

Inhibition of Grb2 expression demonstrates an important role in BCR–ABL-mediated MAPK activation and transformation of primary human hematopoietic cells

Published:2010-11-12 Issue:2 Volume:25 Page:305-312
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Modi H,Li L,Chu S,Rossi J,Yee J-K,Bhatia R

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010257.pdf

Reference31 articles.

1. Rowley JD . Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293.

2. de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1982; 300: 765–767.

3. Lugo TG, Pendergast AM, Muller AJ, Witte ON . Tyrosine kinase activity and transformation potency of BCR-ABL oncogene products. Science 1990; 247: 1079–1082.

4. Zhang X, Ren R . Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 1998; 92: 3829–3840.

5. Deininger MW, Druker BJ . Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev 2003; 55: 401–423.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia;Cell Communication and Signaling;2024-06-07

2. In the Pipeline: Emerging Therapy for CML;Pathogenesis and Treatment of Leukemia;2023

3. Molecular Implications of BCR-ABL1 in Hematological Malignancies;Reference Module in Biomedical Sciences;2023

4. Higher‐order interactions of Bcr‐Abl can broaden chronic myeloid leukemia (CML) drug repertoire;Protein Science;2022-12-28

5. Verbascoside potentiates the effect of tyrosine kinase inhibitors on the induction of apoptosis and oxidative stress via the Abl-mediated MAPK signalling pathway in chronic myeloid leukaemia;Experimental and Therapeutic Medicine;2022-06-14